<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32029478</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>295</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>20</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.</ArticleTitle><Pagination><StartPage>3808</StartPage><EndPage>3825</EndPage><MedlinePgn>3808-3825</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA119.011215</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease, characterized by the selective loss of motor neurons leading to paralysis. Mutations in the gene encoding superoxide dismutase 1 (SOD1) are the second most common cause of familial ALS, and considerable evidence suggests that these mutations result in an increase in toxicity due to protein misfolding. We previously demonstrated in the SOD1<sup>G93A</sup> rat model that misfolded SOD1 exists as distinct conformers and forms deposits on mitochondrial subpopulations. Here, using SOD1<sup>G93A</sup> rats and conformation-restricted antibodies specific for misfolded SOD1 (B8H10 and AMF7-63), we identified the interactomes of the mitochondrial pools of misfolded SOD1. This strategy identified binding proteins that uniquely interacted with either AMF7-63 or B8H10-reactive SOD1 conformers as well as a high proportion of interactors common to both conformers. Of this latter set, we identified the E3 ubiquitin ligase TNF receptor-associated factor 6 (TRAF6) as a SOD1 interactor, and we determined that exposure of the SOD1 functional loops facilitates this interaction. Of note, this conformational change was not universally fulfilled by all SOD1 variants and differentiated TRAF6 interacting from TRAF6 noninteracting SOD1 variants. Functionally, TRAF6 stimulated polyubiquitination and aggregation of the interacting SOD1 variants. TRAF6 E3 ubiquitin ligase activity was required for the former but was dispensable for the latter, indicating that TRAF6-mediated polyubiquitination and aggregation of the SOD1 variants are independent events. We propose that the interaction between misfolded SOD1 and TRAF6 may be relevant to the etiology of ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 Semmler et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Semmler</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagn&#xe9;</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H3T 1J4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Pranav</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8591-7664</Identifier><AffiliationInfo><Affiliation>Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickles</LastName><ForeName>Sarah R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H3T 1J4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baudouin</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamon-Keromen</LastName><ForeName>Emeline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Pierre et Marie Curie, 75005 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Destroismaisons</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalfallah</LastName><ForeName>Yousra</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H3T 1J4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaineau</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Montreal Neurological Institute, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caron</LastName><ForeName>Elise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayne</LastName><ForeName>Andrew N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trempe</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cashman</LastName><ForeName>Neil R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0002-0080-1006</Identifier><AffiliationInfo><Affiliation>Department of Medicine (Neurology), University of British Columbia and Vancouver Coastal Health Research Institute, Brain Research Centre, Vancouver, British Columbia V6T 2B5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Star</LastName><ForeName>Alexandra T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, K1A 0R6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haqqani</LastName><ForeName>Arsalan S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, K1A 0R6, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durcan</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Montreal Neurological Institute, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meiering</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Guelph-Waterloo Centre for Graduate Work in Chemistry and Biochemistry, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Janice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario M5T 0S8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandvaux</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H3T 1J4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plotkin</LastName><ForeName>Steven S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Physics and Astronomy, University of British Columbia, Vancouver, British Columbia V6T 1Z1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McBride</LastName><ForeName>Heidi M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurosurgery, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Montreal Neurological Institute, McGill University, Montr&#xe9;al, Quebec H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vande Velde</LastName><ForeName>Christine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5926-1529</Identifier><AffiliationInfo><Affiliation>Centre de Recherche du Centre Hospitalier de Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H2X 0A9, Canada c.vande.velde@umontreal.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Medicine, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H3T 1J4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Universit&#xe9; de Montr&#xe9;al, Montr&#xe9;al, Quebec H3T 1J4, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>3HCS.A</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048029">TNF Receptor-Associated Factor 6</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055647" MajorTopicYN="N">Rats, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048029" MajorTopicYN="N">TNF Receptor-Associated Factor 6</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TNF receptor&#x2013;associated factor (TRAF)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">protein misfolding</Keyword><Keyword MajorTopicYN="N">superoxide dismutase (SOD)</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest with the contents of this article</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32029478</ArticleId><ArticleId IdType="pmc">PMC7086032</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA119.011215</ArticleId><ArticleId IdType="pii">S0021-9258(17)48775-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., and Deng H. X. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59&#x2013;62 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A. E., Chi&#xf2; A., and Traynor B. J. (2014) State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17&#x2013;23 10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudette M., Hirano M., and Siddique T. (2000) Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 83&#x2013;89 10.1080/14660820050515377</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515377</ArticleId><ArticleId IdType="pubmed">11467054</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., and Vande Velde C. (2012) Misfolded SOD1 and ALS: zeroing in on mitochondria. Amyotroph. Lateral Scler. 13, 333&#x2013;340 10.3109/17482968.2012.648645</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.648645</ArticleId><ArticleId IdType="pubmed">22471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng X., Cashman N. R., and Plotkin S. S. (2018) Prediction of misfolding-specific epitopes in SOD1 using collective coordinates. J. Phys. Chem. B 122, 11662&#x2013;11676 10.1021/acs.jpcb.8b07680</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.8b07680</ArticleId><ArticleId IdType="pubmed">30351123</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P., Kriz J., Gravel M., Soucy G., Bareil C., Gravel C., and Julien J. P. (2014) Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis. Mol. Ther. 22, 498&#x2013;510 10.1038/mt.2013.239</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.239</ArticleId><ArticleId IdType="pmc">PMC3944333</ArticleId><ArticleId IdType="pubmed">24394188</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts B. R., Lim N. K., McAllum E. J., Donnelly P. S., Hare D. J., Doble P. A., Turner B. J., Price K. A., Lim S. C., Paterson B. M., Hickey J. L., Rhoads T. W., Williams J. R., Kanninen K. M., Hung L. W., et al. (2014) Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 34, 8021&#x2013;8031 10.1523/JNEUROSCI.4196-13.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4196-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F., Soucy G., Larivi&#xe8;re R., and Julien J. P. (2010) Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J. Neurochem. 113, 1188&#x2013;1199 10.1111/j.1471-4159.2010.06683.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2010.06683.x</ArticleId><ArticleId IdType="pubmed">20345765</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlasi R. S., Malik R., Corrales C. I., Tzeplaeff L., Whitelegge J. P., Cashman N. R., and Bitan G. (2018) Investigation of anti-SOD1 antibodies yields new structural insight into SOD1 misfolding and surprising behavior of the antibodies themselves. ACS Chem. Biol. 13, 2794&#x2013;2807 10.1021/acschembio.8b00729</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00729</ArticleId><ArticleId IdType="pmc">PMC6475120</ArticleId><ArticleId IdType="pubmed">30110532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Semmler S., Broom H. R., Destroismaisons L., Legroux L., Arbour N., Meiering E., Cashman N. R., and Vande Velde C. (2016) ALS-linked misfolded SOD1 species have divergent impacts on mitochondria. Acta Neuropathol. Commun. 4, 43 10.1186/s40478-016-0313-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0313-8</ArticleId><ArticleId IdType="pmc">PMC4847257</ArticleId><ArticleId IdType="pubmed">27121871</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H. N., Tjostheim S., Dasilva K., Taylor D., Zhao B., Rakhit R., Brown M., Chakrabartty A., McLaurin J., and Robertson J. (2012) Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis. J Neurosci. 32, 8791&#x2013;8799 10.1523/JNEUROSCI.5053-11.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5053-11.2012</ArticleId><ArticleId IdType="pmc">PMC6622344</ArticleId><ArticleId IdType="pubmed">22745481</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi S., Fujiwara N., Ido A., Oono M., Takeuchi Y., Tateno M., Suzuki K., Takahashi R., Tooyama I., Taniguchi N., Julien J. P., and Urushitani M. (2010) Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice. J. Neuropathol. Exp. Neurol. 69, 1044&#x2013;1056 10.1097/NEN.0b013e3181f4a90a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181f4a90a</ArticleId><ArticleId IdType="pubmed">20838241</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Ezzi S. A., and Julien J. P. (2007) Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 104, 2495&#x2013;2500 10.1073/pnas.0606201104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606201104</ArticleId><ArticleId IdType="pmc">PMC1790867</ArticleId><ArticleId IdType="pubmed">17277077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B., Marciniuk K., Gibbs E., Yousefi M., Napper S., and Cashman N. R. (2019) Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1. Vaccine 37, 4920&#x2013;4927 10.1016/j.vaccine.2019.07.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.07.044</ArticleId><ArticleId IdType="pubmed">31324499</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M., Welt T., Wirth F., Montrasio F., Preisig D., McAfoose J., Vieira F. G., Kulic L., Sp&#xe4;ni C., Stehle T., Perrin S., Weber M., Hock C., Nitsch R. M., and Grimm J. (2018) A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis. Sci. Transl. Med. 10, eaah3924 10.1126/scitranslmed.aah3924</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah3924</ArticleId><ArticleId IdType="pubmed">30518612</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Destroismaisons L., Peyrard S. L., Cadot S., Rouleau G. A., Brown R. H. Jr., Julien J. P., Arbour N., and Vande Velde C. (2013) Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1. Hum. Mol. Genet. 22, 3947&#x2013;3959 10.1093/hmg/ddt249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt249</ArticleId><ArticleId IdType="pmc">PMC5052069</ArticleId><ArticleId IdType="pubmed">23736301</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., Miller T. M., Cashman N. R., and Cleveland D. W. (2008) Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc. Natl. Acad. Sci. U.S.A. 105, 4022&#x2013;4027 10.1073/pnas.0712209105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0712209105</ArticleId><ArticleId IdType="pmc">PMC2268797</ArticleId><ArticleId IdType="pubmed">18296640</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Lillo C., Jonsson P. A., Vande Velde C., Ward C. M., Miller T. M., Subramaniam J. R., Rothstein J. D., Marklund S., Andersen P. M., Br&#xe4;nnstrom T., Gredal O., Wong P. C., Williams D. S., and Cleveland D. W. (2004) Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43, 5&#x2013;17 10.1016/j.neuron.2004.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Casareno R. L., Waggoner D., and Gitlin J. D. (1998) The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J. Biol. Chem. 273, 23625&#x2013;23628 10.1074/jbc.273.37.23625</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.37.23625</ArticleId><ArticleId IdType="pubmed">9726962</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., and Cleveland D. W. (2010) Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67, 575&#x2013;587 10.1016/j.neuron.2010.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov M. V., Jones M. R., Rouillard A. D., Fernandez N. F., Duan Q., Wang Z., Koplev S., Jenkins S. L., Jagodnik K. M., Lachmann A., McDermott M. G., Monteiro C. D., Gundersen G. W., and Ma'ayan A. (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90&#x2013;W97 10.1093/nar/gkw377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E. Y., Tan C. M., Kou Y., Duan Q., Wang Z., Meirelles G. V., Clark N. R., and Ma'ayan A. (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 10.1186/1471-2105-14-128</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M. C., Lee J., and Choi Y. (2015) Tumor necrosis factor receptor-associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol. Rev. 266, 72&#x2013;92 10.1111/imr.12302</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12302</ArticleId><ArticleId IdType="pmc">PMC4799835</ArticleId><ArticleId IdType="pubmed">26085208</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Ji., Ishida T., Tsukamoto N., Kobayashi N., Naito A., Azuma S., and Yamamoto T. (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14&#x2013;24 10.1006/excr.1999.4733</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.1999.4733</ArticleId><ArticleId IdType="pubmed">10623461</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakhaei P., Genin P., Civas A., and Hiscott J. (2009) RIG-I-like receptors: sensing and responding to RNA virus infection. Semin. Immunol. 21, 215&#x2013;222 10.1016/j.smim.2009.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2009.05.001</ArticleId><ArticleId IdType="pubmed">19539500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley J. R., and Pober J. S. (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482&#x2013;6491 10.1038/sj.onc.1204788</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1204788</ArticleId><ArticleId IdType="pubmed">11607847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C. S., and Kehrl J. H. (2010) TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci. Signal. 3, ra42 10.1126/scisignal.2000751</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2000751</ArticleId><ArticleId IdType="pmc">PMC6335036</ArticleId><ArticleId IdType="pubmed">20501938</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares J. F., Duran A., Yajima T., Pasparakis M., Moscat J., and Diaz-Meco M. T. (2013) K63 polyubiquitination and activation of mTOR by the p62&#x2013;TRAF6 complex in nutrient-activated cells. Mol. Cell 51, 283&#x2013;296 10.1016/j.molcel.2013.06.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.06.020</ArticleId><ArticleId IdType="pmc">PMC3971544</ArticleId><ArticleId IdType="pubmed">23911927</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazio F., Strappazzon F., Antonioli M., Bielli P., Cianfanelli V., Bordi M., Gretzmeier C., Dengjel J., Piacentini M., Fimia G. M., and Cecconi F. (2013) mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat. Cell Biol. 15, 406&#x2013;416 10.1038/ncb2708</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2708</ArticleId><ArticleId IdType="pubmed">23524951</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul P. K., Bhatnagar S., Mishra V., Srivastava S., Darnay B. G., Choi Y., and Kumar A. (2012) The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol. Cell. Biol. 32, 1248&#x2013;1259 10.1128/MCB.06351-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.06351-11</ArticleId><ArticleId IdType="pmc">PMC3302447</ArticleId><ArticleId IdType="pubmed">22290431</ArticleId></ArticleIdList></Reference><Reference><Citation>West A. P., Brodsky I. E., Rahner C., Woo D. K., Erdjument-Bromage H., Tempst P., Walsh M. C., Choi Y., Shadel G. S., and Ghosh S. (2011) TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472, 476&#x2013;480 10.1038/nature09973</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09973</ArticleId><ArticleId IdType="pmc">PMC3460538</ArticleId><ArticleId IdType="pubmed">21525932</ArticleId></ArticleIdList></Reference><Reference><Citation>Min Y., Wi S. M., Shin D., Chun E., and Lee K. Y. (2017) Peroxiredoxin-6 negatively regulates bactericidal activity and NF-&#x3ba;B activity by interrupting TRAF6-ECSIT complex. Front. Cell. Infect. Microbiol. 7, 94 10.3389/fcimb.2017.00094</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2017.00094</ArticleId><ArticleId IdType="pmc">PMC5364181</ArticleId><ArticleId IdType="pubmed">28393051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N. R., Ban J., Lee N. J., Yi C. M., Choi J. Y., Kim H., Lee J. K., Seong J., Cho N. H., Jung J. U., and Inn K. S. (2018) Activation of RIG-I-mediated antiviral signaling triggers autophagy through the MAVS&#x2013;TRAF6&#x2013;Beclin-1 signaling axis. Front. Immunol. 9, 2096 10.3389/fimmu.2018.02096</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02096</ArticleId><ArticleId IdType="pmc">PMC6143786</ArticleId><ArticleId IdType="pubmed">30258449</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata H., Sakaguchi M., Kataoka K., and Huh N. H. (2013) SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria. Mol. Biol. Cell 24, 2772&#x2013;2784 10.1091/mbc.e13-01-0016</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e13-01-0016</ArticleId><ArticleId IdType="pmc">PMC3771941</ArticleId><ArticleId IdType="pubmed">23885119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim G. G., Chua D. S., Basil A. H., Chan H. Y., Chai C., Arumugam T., and Lim K. L. (2015) Cytosolic PTEN-induced putative kinase 1 is stabilized by the NF-&#x3ba;B pathway and promotes non-selective mitophagy. J. Biol. Chem. 290, 16882&#x2013;16893 10.1074/jbc.M114.622399</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.622399</ArticleId><ArticleId IdType="pmc">PMC4505434</ArticleId><ArticleId IdType="pubmed">25987559</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchelli S., Codrich M., Marcuzzi F., Pinto M., Vilotti S., Biagioli M., Ferrer I., and Gustincich S. (2010) TRAF6 promotes atypical ubiquitination of mutant DJ-1 and &#x3b1;-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains. Hum. Mol. Genet. 19, 3759&#x2013;3770 10.1093/hmg/ddq290</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq290</ArticleId><ArticleId IdType="pubmed">20634198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J. Y., Park H. R., Lee S. J., Lee S. H., Kim J. S., Jung Y. S., Hwang S. H., Ha N. C., Seol W. G., Lee J., and Park B. J. (2013) Elevated TRAF2/6 expression in Parkinson's disease is caused by the loss of Parkin E3 ligase activity. Lab. Invest. 93, 663&#x2013;676 10.1038/labinvest.2013.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.60</ArticleId><ArticleId IdType="pubmed">23608757</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilotti S., Codrich M., Dal Ferro M., Pinto M., Ferrer I., Collavin L., Gustincich S., and Zucchelli S. (2012) Parkinson's disease DJ-1 L166P alters rRNA biogenesis by exclusion of TTRAP from the nucleolus and sequestration into cytoplasmic aggregates via TRAF6. PLoS One 7, e35051 10.1371/journal.pone.0035051</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035051</ArticleId><ArticleId IdType="pmc">PMC3332112</ArticleId><ArticleId IdType="pubmed">22532838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchelli S., Marcuzzi F., Codrich M., Agostoni E., Vilotti S., Biagioli M., Pinto M., Carnemolla A., Santoro C., Gustincich S., and Persichetti F. (2011) Tumor necrosis factor receptor&#x2013;associated factor 6 (TRAF6) associates with huntingtin protein and promotes its atypical ubiquitination to enhance aggregate formation. J. Biol. Chem. 286, 25108&#x2013;25117 10.1074/jbc.M110.187591</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.187591</ArticleId><ArticleId IdType="pmc">PMC3137084</ArticleId><ArticleId IdType="pubmed">21454471</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., Farrelly S., and McCarthy J. V. (2013) Presenilins are novel substrates for TRAF6-mediated ubiquitination. Cell. Signal. 25, 1769&#x2013;1779 10.1016/j.cellsig.2013.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2013.05.015</ArticleId><ArticleId IdType="pubmed">23707529</ArticleId></ArticleIdList></Reference><Reference><Citation>Broering T. J., Wang H., Boatright N. K., Wang Y., Baptista K., Shayan G., Garrity K. A., Kayatekin C., Bosco D. A., Matthews C. R., Ambrosino D. M., Xu Z., and Babcock G. J. (2013) Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1. PLoS One 8, e61210 10.1371/journal.pone.0061210</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061210</ArticleId><ArticleId IdType="pmc">PMC3629177</ArticleId><ArticleId IdType="pubmed">23613814</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu J. R., Geetha T., and Wooten M. W. (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J. Neurochem. 94, 192&#x2013;203 10.1111/j.1471-4159.2005.03181.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03181.x</ArticleId><ArticleId IdType="pubmed">15953362</ArticleId></ArticleIdList></Reference><Reference><Citation>Popovic D., Vucic D., and Dikic I. (2014) Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20, 1242&#x2013;1253 10.1038/nm.3739</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3739</ArticleId><ArticleId IdType="pubmed">25375928</ArticleId></ArticleIdList></Reference><Reference><Citation>Iconomou M., and Saunders D. N. (2016) Systematic approaches to identify E3 ligase substrates. Biochem. J. 473, 4083&#x2013;4101 10.1042/BCJ20160719</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160719</ArticleId><ArticleId IdType="pmc">PMC5103871</ArticleId><ArticleId IdType="pubmed">27834739</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce N. W., Kleiger G., Shan S. O., and Deshaies R. J. (2009) Detection of sequential polyubiquitylation on a millisecond timescale. Nature 462, 615&#x2013;619 10.1038/nature08595</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08595</ArticleId><ArticleId IdType="pmc">PMC2791906</ArticleId><ArticleId IdType="pubmed">19956254</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyaud E., Mis M., Laurent E. M., Dunham W. H., Couzens A. L., Robitaille M., Gingras A. C., Angers S., and Raught B. (2015) BioID-based identification of Skp cullin F-box (SCF)&#x3b2;-TrCP1/2 E3 ligase substrates. Mol. Cell. Proteomics 14, 1781&#x2013;1795 10.1074/mcp.M114.045658</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M114.045658</ArticleId><ArticleId IdType="pmc">PMC4587326</ArticleId><ArticleId IdType="pubmed">25900982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K. Z., Galson D. L., and Auron P. E. (2010) TRAF6 is autoinhibited by an intramolecular interaction which is counteracted by trans-ubiquitination. J. Cell. Biochem. 110, 763&#x2013;771 10.1002/jcb.22589</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22589</ArticleId><ArticleId IdType="pmc">PMC3407548</ArticleId><ArticleId IdType="pubmed">20512936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishida T., Mizushima Si., Azuma S., Kobayashi N., Tojo T., Suzuki K., Aizawa S., Watanabe T., Mosialos G., Kieff E., Yamamoto T., and Inoue J. (1996) Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745&#x2013;28748 10.1074/jbc.271.46.28745</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.46.28745</ArticleId><ArticleId IdType="pubmed">8910514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z., Xiong J., Takeuchi M., Kurama T., and Goeddel D. V. (1996) TRAF6 is a signal transducer for interleukin-1. Nature 383, 443&#x2013;446 10.1038/383443a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/383443a0</ArticleId><ArticleId IdType="pubmed">8837778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamothe B., Campos A. D., Webster W. K., Gopinathan A., Hur L., and Darnay B. G. (2008) The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283, 24871&#x2013;24880 10.1074/jbc.M802749200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802749200</ArticleId><ArticleId IdType="pmc">PMC2529010</ArticleId><ArticleId IdType="pubmed">18617513</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Zhang Z., Zhang Z., Wang Y., Li C., Wang X., He F., Sun L., Jiao S., Shi W., and Zhou Z. (2015) Structural insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling. J. Biol. Chem. 290, 26811&#x2013;26820 10.1074/jbc.M115.666578</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.666578</ArticleId><ArticleId IdType="pmc">PMC4646334</ArticleId><ArticleId IdType="pubmed">26385923</ArticleId></ArticleIdList></Reference><Reference><Citation>Geetha T., and Wooten M. W. (2002) Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett. 512, 19&#x2013;24 10.1016/S0014-5793(02)02286-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(02)02286-X</ArticleId><ArticleId IdType="pubmed">11852044</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmack G., Schorpp K., Kutzner K., Gehring T., Brenke J. K., Hadian K., and Krappmann D. (2017) YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-&#x3ba;B. Elife 6, e22416 10.7554/eLife.22416</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.22416</ArticleId><ArticleId IdType="pmc">PMC5340530</ArticleId><ArticleId IdType="pubmed">28244869</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh J., Zetterstr&#xf6;m P., Andersen P. M., Br&#xe4;nnstr&#xf6;m T., Graffmo K. S., Jonsson P. A., Lang L., Danielsson J., Oliveberg M., and Marklund S. L. (2015) Structural and kinetic analysis of protein-aggregate strains in vivo using binary epitope mapping. Proc. Natl. Acad. Sci. U.S.A. 112, 4489&#x2013;4494 10.1073/pnas.1419228112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1419228112</ArticleId><ArticleId IdType="pmc">PMC4394267</ArticleId><ArticleId IdType="pubmed">25802384</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom H. R., Rumfeldt J. A., Vassall K. A., and Meiering E. M. (2015) Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1. Protein Sci. 24, 2081&#x2013;2089 10.1002/pro.2803</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.2803</ArticleId><ArticleId IdType="pmc">PMC4815230</ArticleId><ArticleId IdType="pubmed">26362407</ArticleId></ArticleIdList></Reference><Reference><Citation>Broom H. R., Vassall K. A., Rumfeldt J. A., Doyle C. M., Tong M. S., Bonner J. M., and Meiering E. M. (2016) Combined isothermal titration and differential scanning calorimetry define three-state thermodynamics of fALS-associated mutant Apo SOD1 dimers and an increased population of folded monomer. Biochemistry 55, 519&#x2013;533 10.1021/acs.biochem.5b01187</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.5b01187</ArticleId><ArticleId IdType="pubmed">26710831</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle C. M., Rumfeldt J. A., Broom H. R., Sekhar A., Kay L. E., and Meiering E. M. (2016) Concurrent increases and decreases in local stability and conformational heterogeneity in Cu,Zn superoxide dismutase variants revealed by temperature-dependence of amide chemical shifts. Biochemistry 55, 1346&#x2013;1361 10.1021/acs.biochem.5b01133</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.5b01133</ArticleId><ArticleId IdType="pubmed">26849066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamothe B., Besse A., Campos A. D., Webster W. K., Wu H., and Darnay B. G. (2007) Site-specific Lys-63&#x2013;linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I&#x3ba;B kinase activation. J. Biol. Chem. 282, 4102&#x2013;4112 10.1074/jbc.M609503200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609503200</ArticleId><ArticleId IdType="pmc">PMC3221607</ArticleId><ArticleId IdType="pubmed">17135271</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Muto T., Kleppe M., Bolanos L. C., Hueneman K. M., Walker C. S., Sampson L., Wellendorf A. M., Chetal K., Choi K., Salomonis N., Choi Y., Zheng Y., Cancelas J. A., Levine R. L., and Starczynowski D. T. (2018) TRAF6 mediates basal activation of NF-&#x3ba;B necessary for hematopoietic stem cell homeostasis. Cell Rep. 22, 1250&#x2013;1262 10.1016/j.celrep.2018.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.01.013</ArticleId><ArticleId IdType="pmc">PMC5971064</ArticleId><ArticleId IdType="pubmed">29386112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhakar A. L., Tannis L. L., Zeindler C., Russo M. P., Jobin C., Park D. S., MacPherson S., and Barker P. A. (2002) Constitutive nuclear factor-&#x3ba;B activity is required for central neuron survival. J. Neurosci. 22, 8466&#x2013;8475 10.1523/JNEUROSCI.22-19-08466.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-19-08466.2002</ArticleId><ArticleId IdType="pmc">PMC6757785</ArticleId><ArticleId IdType="pubmed">12351721</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Ullrich R., M&#xe9;met S., Lilienbaum A., Feuillard J., Rapha&#xeb;l M., and Israel A. (1996) NF-&#x3ba;B activity in transgenic mice: developmental regulation and tissue specificity. Development 122, 2117&#x2013;2128</Citation><ArticleIdList><ArticleId IdType="pubmed">8681793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt B., and Kaltschmidt C. (2009) NF-&#x3ba;B in the nervous system. Cold Spring Harb. Perspect. Biol. 1, a001271 10.1101/cshperspect.a001271</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a001271</ArticleId><ArticleId IdType="pmc">PMC2773634</ArticleId><ArticleId IdType="pubmed">20066105</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes A. E., Ferraiuolo L., Haidet-Phillips A. M., Schmelzer L., Braun L., Miranda C. J., Ladner K. J., Bevan A. K., Foust K. D., Godbout J. P., Popovich P. G., Guttridge D. C., and Kaspar B. K. (2014) Microglia induce motor neuron death via the classical NF-&#x3ba;B pathway in amyotrophic lateral sclerosis. Neuron 81, 1009&#x2013;1023 10.1016/j.neuron.2014.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouali Alami N., Schurr C., Olde Heuvel F., Tang L., Li Q., Tasdogan A., Kimbara A., Nettekoven M., Ottaviani G., Raposo C., R&#xf6;ver S., Rogers-Evans M., Rothenh&#xe4;usler B., Ullmer C., Fingerle J., et al. (2018) NF-&#x3ba;B activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS. EMBO J. 37, e98697 10.15252/embj.201798697</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798697</ArticleId><ArticleId IdType="pmc">PMC6092622</ArticleId><ArticleId IdType="pubmed">29875132</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K. K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C. S., Bel Hadj S., Zandona A., Julien J. P., Shah S. B., and Cleveland D. W. (2011) Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS One 6, e22031 10.1371/journal.pone.0022031</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Roselli F., Singh K., Leptien K., Julien J. P., Gros-Louis F., and Caroni P. (2013) Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron 80, 80&#x2013;96 10.1016/j.neuron.2013.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.027</ArticleId><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R., Robertson J., Vande Velde C., Horne P., Ruth D. M., Griffin J., Cleveland D. W., Cashman N. R., and Chakrabartty A. (2007) An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat. Med. 13, 754&#x2013;759 10.1038/nm1559</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1559</ArticleId><ArticleId IdType="pubmed">17486090</ArticleId></ArticleIdList></Reference><Reference><Citation>Carithers L. J., Ardlie K., Barcus M., Branton P. A., Britton A., Buia S. A., Compton C. C., DeLuca D. S., Peter-Demchok J., Gelfand E. T., Guan P., Korzeniewski G. E., Lockhart N. C., Rabiner C. A., Rao A. K., et al. (2015) A novel approach to high-quality postmortem tissue procurement: the GTEx Project. Biopreserv. Biobank. 13, 311&#x2013;319 10.1089/bio.2015.0032</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2015.0032</ArticleId><ArticleId IdType="pmc">PMC4675181</ArticleId><ArticleId IdType="pubmed">26484571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruegsegger C., Maharjan N., Goswami A., Fil&#xe9;zac de L'Etang A., Weis J., Troost D., Heller M., Gut H., and Saxena S. (2016) Aberrant association of misfolded SOD1 with Na+/K+ATPase-&#x3b1;3 impairs its activity and contributes to motor neuron vulnerability in ALS. Acta Neuropathol. 131, 427&#x2013;451 10.1007/s00401-015-1510-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1510-4</ArticleId><ArticleId IdType="pubmed">26619836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m P., Graffmo K. S., Andersen P. M., Br&#xe4;nnstr&#xf6;m T., and Marklund S. L. (2011) Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice. J. Biol. Chem. 286, 20130&#x2013;20136 10.1074/jbc.M111.218842</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.218842</ArticleId><ArticleId IdType="pmc">PMC3121531</ArticleId><ArticleId IdType="pubmed">21493711</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y., Morita E., Fukada Y., Doi K., Yasui K., Kitayama M., Nakano T., and Nakashima K. (2008) Adherent monomer-misfolded SOD1. PLoS One 3, e3497 10.1371/journal.pone.0003497</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003497</ArticleId><ArticleId IdType="pmc">PMC2567031</ArticleId><ArticleId IdType="pubmed">18946506</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M. R., Ge W. W., Elkabes S., and Li H. (2008) Amyotrophic lateral sclerosis: protein chaperone dysfunction revealed by proteomic studies of animal models. Proteomics Clin. Appl. 2, 670&#x2013;684 10.1002/prca.200780023</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.200780023</ArticleId><ArticleId IdType="pmc">PMC2705162</ArticleId><ArticleId IdType="pubmed">19578526</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Torres A. S., and O'Halloran T. V. (2004) Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J. 23, 2872&#x2013;2881 10.1038/sj.emboj.7600276</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600276</ArticleId><ArticleId IdType="pmc">PMC1150991</ArticleId><ArticleId IdType="pubmed">15215895</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G. S., Antonyuk S. V., and Hasnain S. S. (2016) A faulty interaction between SOD1 and hCCS in neurodegenerative disease. Sci. Rep. 6, 27691 10.1038/srep27691</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27691</ArticleId><ArticleId IdType="pmc">PMC4901319</ArticleId><ArticleId IdType="pubmed">27282955</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam J. R., Lyons W. E., Liu J., Bartnikas T. B., Rothstein J., Price D. L., Cleveland D. W., Gitlin J. D., and Wong P. C. (2002) Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5, 301&#x2013;307 10.1038/nn823</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn823</ArticleId><ArticleId IdType="pubmed">11889469</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr I. S., McCann E. P., Benyamin B., Peters T. J., Twine N. A., Zhang K. Y., Zhao Q., Zhang Z. H., Rowe D. B., Nicholson G. A., Bauer D., Clark S. J., Blair I. P., and Williams K. L. (2019) Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression. Sci. Rep. 9, 8254 10.1038/s41598-019-44765-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44765-4</ArticleId><ArticleId IdType="pmc">PMC6547746</ArticleId><ArticleId IdType="pubmed">31164693</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheoud D., Sugiura A., Bellemare-Pelletier A., Laplante A., Rondeau C., Chemali M., Fazel A., Bergeron J. J., Trudeau L. E., Burelle Y., Gagnon E., McBride H. M., and Desjardins M. (2016) Parkinson's disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell 166, 314&#x2013;327 10.1016/j.cell.2016.05.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.039</ArticleId><ArticleId IdType="pubmed">27345367</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheoud D., Cannon T., Voisin A., Penttinen A. M., Ramet L., Fahmy A. M., Ducrot C., Laplante A., Bourque M. J., Zhu L., Cayrol R., Le Campion A., McBride H. M., Gruenheid S., Trudeau L. E., and Desjardins M. (2019) Intestinal infection triggers Parkinson's disease-like symptoms in Pink1(&#x2212;/&#x2212;) mice. Nature 571, 565&#x2013;569 10.1038/s41586-019-1405-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1405-y</ArticleId><ArticleId IdType="pubmed">31316206</ArticleId></ArticleIdList></Reference><Reference><Citation>Granatiero V., and Manfredi G. (2019) Mitochondrial transport and turnover in the pathogenesis of amyotrophic lateral sclerosis. Biology 8, E36 10.3390/biology8020036</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020036</ArticleId><ArticleId IdType="pmc">PMC6627920</ArticleId><ArticleId IdType="pubmed">31083575</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa T., Homma K., Yamaguchi N., Kadowaki H., Tsuburaya N., Naguro I., Matsuzawa A., Takeda K., Takahashi Y., Goto J., Tsuji S., Nishitoh H., and Ichijo H. (2012) A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants. Ann. Neurol. 72, 739&#x2013;749 10.1002/ana.23668</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23668</ArticleId><ArticleId IdType="pubmed">23280792</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P. M., Nilsson P., Ker&#xe4;nen M. L., Forsgren L., H&#xe4;gglund J., Karlsborg M., Ronnevi L. O., Gredal O., and Marklund S. L. (1997) Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 120, 1723&#x2013;1737 10.1093/brain/120.10.1723</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/120.10.1723</ArticleId><ArticleId IdType="pubmed">9365366</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Johnson J. L., Agar N. Y., and Agar J. N. (2008) Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 6, e170 10.1371/journal.pbio.0060170</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060170</ArticleId><ArticleId IdType="pmc">PMC2486295</ArticleId><ArticleId IdType="pubmed">18666828</ArticleId></ArticleIdList></Reference><Reference><Citation>Strickson S., Emmerich C. H., Goh E. T. H., Zhang J., Kelsall I. R., Macartney T., Hastie C. J., Knebel A., Peggie M., Marchesi F., Arthur J. S. C., and Cohen P. (2017) Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling. Proc. Natl. Acad. Sci. U.S.A. 114, E3481&#x2013;E3489 10.1073/pnas.1702367114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1702367114</ArticleId><ArticleId IdType="pmc">PMC5410814</ArticleId><ArticleId IdType="pubmed">28404732</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H. W., Liao H. M., Peng W. H., Lin H. R., Chen C. H., and Chen G. C. (2013) Atg9 interacts with dTRAF2/TRAF6 to regulate oxidative stress-induced JNK activation and autophagy induction. Dev. Cell 27, 489&#x2013;503 10.1016/j.devcel.2013.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2013.10.017</ArticleId><ArticleId IdType="pubmed">24268699</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenekeci U., Poppe M., Beuerlein K., Buro C., M&#xfc;ller H., Weiser H., Kettner-Buhrow D., Porada K., Newel D., Xu M., Chen Z. J., Busch J., Schmitz M. L., and Kracht M. (2016) K63-ubiquitylation and TRAF6 pathways regulate mammalian P-body formation and mRNA decapping. Mol. Cell 62, 943&#x2013;957 10.1016/j.molcel.2016.05.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.017</ArticleId><ArticleId IdType="pubmed">27315556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Bolanos L. C., Choi K., Liu X., Christie S., Akunuru S., Kumar R., Wang D., Chen X., Greis K. D., Stoilov P., Filippi M. D., Maciejewski J. P., Garcia-Manero G., Weirauch M. T., et al. (2017) Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia. Nat. Immunol. 18, 236&#x2013;245 10.1038/ni.3654</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3654</ArticleId><ArticleId IdType="pmc">PMC5423405</ArticleId><ArticleId IdType="pubmed">28024152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz L., Diaz-Meco M. T., Nakano H., and Moscat J. (2000) The atypical PKC-interacting protein p62 channels NF-&#x3ba;B activation by the IL-1-TRAF6 pathway. EMBO J. 19, 1576&#x2013;1586 10.1093/emboj/19.7.1576</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/19.7.1576</ArticleId><ArticleId IdType="pmc">PMC310227</ArticleId><ArticleId IdType="pubmed">10747026</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno H., Yamamoto T., Yamazaki K., Gohda J., Akiyama T., Semba K., Goto H., Kato A., Yujiri T., Imai T., Kawaguchi Y., Su B., Takeuchi O., Akira S., Tsunetsugu-Yokota Y., and Inoue J. (2009) TRAF6 establishes innate immune responses by activating NF-&#x3ba;B and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 4, e5674 10.1371/journal.pone.0005674</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005674</ArticleId><ArticleId IdType="pmc">PMC2682567</ArticleId><ArticleId IdType="pubmed">19479062</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland D. S., Liu J., She Y., Goad B., Maragakis N. J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L. J., Cleveland D. W., and Rothstein J. D. (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U.S.A. 99, 1604&#x2013;1609 10.1073/pnas.032539299</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan P. H., Kawase M., Murakami K., Chen S. F., Li Y., Calagui B., Reola L., Carlson E., and Epstein C. J. (1998) Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 18, 8292&#x2013;8299 10.1523/JNEUROSCI.18-20-08292.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-20-08292.1998</ArticleId><ArticleId IdType="pmc">PMC6792858</ArticleId><ArticleId IdType="pubmed">9763473</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Arbour N., and Vande Velde C. (2014) Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria. J. Vis. Exp. 2014, 51887 10.3791/51887</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/51887</ArticleId><ArticleId IdType="pmc">PMC4828110</ArticleId><ArticleId IdType="pubmed">25285411</ArticleId></ArticleIdList></Reference><Reference><Citation>Haqqani A. S., Delaney C. E., Tremblay T. L., Sodja C., Sandhu J. K., and Stanimirovic D. B. (2013) Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS 10, 4 10.1186/2045-8118-10-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-10-4</ArticleId><ArticleId IdType="pmc">PMC3560214</ArticleId><ArticleId IdType="pubmed">23305214</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizca&#xed;no J. A., C&#xf4;t&#xe9; R. G., Csordas A., Dianes J. A., Fabregat A., Foster J. M., Griss J., Alpi E., Birim M., Contell J., O'Kelly G., Schoenegger A., Ovelleiro D., P&#xe9;rez-Riverol Y., Reisinger F., et al. (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063&#x2013;D1069 10.1093/nar/gks1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1262</ArticleId><ArticleId IdType="pmc">PMC3531176</ArticleId><ArticleId IdType="pubmed">23203882</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y., Kuta R., Grasmuck C., Prat A., Durham H. D., and Vande Velde C. (2018) TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 8, 7551 10.1038/s41598-018-25767-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25767-0</ArticleId><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Goslin K., Asmussen H., and Banker G. (1998) in Culturing Nerve Cells (Banker G., and Goslin K. eds) 2nd Ed, pp. 339&#x2013;370, MIT Press, Cambridge, MA</Citation></Reference><Reference><Citation>Du Z. W., Chen H., Liu H., Lu J., Qian K., Huang C. L., Zhong X., Fan F., and Zhang S. C. (2015) Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 6, 6626 10.1038/ncomms7626</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7626</ArticleId><ArticleId IdType="pmc">PMC4375778</ArticleId><ArticleId IdType="pubmed">25806427</ArticleId></ArticleIdList></Reference><Reference><Citation>Korchnak A. C., Zhan Y., Aguilar M. T., and Chadee D. N. (2009) Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. Cell. Signal. 21, 1620&#x2013;1625 10.1016/j.cellsig.2009.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.06.008</ArticleId><ArticleId IdType="pmc">PMC2772099</ArticleId><ArticleId IdType="pubmed">19586614</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink K., Duval A., Martel A., Soucy-Faulkner A., and Grandvaux N. (2008) Dual role of NOX2 in respiratory syncytial virus- and Sendai virus-induced activation of NF-&#x3ba;B in airway epithelial cells. J. Immunol. 180, 6911&#x2013;6922 10.4049/jimmunol.180.10.6911</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.10.6911</ArticleId><ArticleId IdType="pubmed">18453612</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Chen J., Barnett K. R., Yang L., Brumley E., and Zhu H. (2013) HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation. J. Biol. Chem. 288, 15035&#x2013;15045 10.1074/jbc.M112.431957</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.431957</ArticleId><ArticleId IdType="pmc">PMC3663524</ArticleId><ArticleId IdType="pubmed">23580651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rengachari S., Groiss S., Devos J. M., Caron E., Grandvaux N., and Panne D. (2018) Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function. Proc. Natl. Acad. Sci. U.S.A. 115, E601&#x2013;E609 10.1073/pnas.1718426115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1718426115</ArticleId><ArticleId IdType="pmc">PMC5789952</ArticleId><ArticleId IdType="pubmed">29317535</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen T. D., and Livak K. J. (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101&#x2013;1108 10.1038/nprot.2008.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.73</ArticleId><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Corpet F. (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10881&#x2013;10890 10.1093/nar/16.22.10881</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/16.22.10881</ArticleId><ArticleId IdType="pmc">PMC338945</ArticleId><ArticleId IdType="pubmed">2849754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Yan R., Roy A., Xu D., Poisson J., and Zhang Y. (2015) The I-TASSER suite: protein structure and function prediction. Nat. Methods 12, 7&#x2013;8 10.1038/nmeth.3213</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3213</ArticleId><ArticleId IdType="pmc">PMC4428668</ArticleId><ArticleId IdType="pubmed">25549265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>